Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity
- PMID: 12486229
- PMCID: PMC139281
- DOI: 10.1073/pnas.262544899
Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity
Abstract
Huntington's disease is a progressive neurodegenerative disease caused by a polyglutamine (polyQ) repeat expansion in the huntingtin protein [Huntington's Disease Collaborative Research Group (1993) Cell 72, 971-983]. To understand the mechanism by which polyQ repeats cause neurodegeneration and cell death, we modeled polyQ neurotoxicity in Caenorhabditis elegans. In our model, expression of N-terminal fragments of human huntingtin causes polyQ-dependent degeneration of neurons. We conducted a genetic screen to identify proteins that protect neurons from the toxic effects of expanded polyQ tracts. Loss of polyQ enhancer-1 (pqe-1) gene function strongly and specifically exacerbates neurodegeneration and cell death, whereas overexpression of a pqe-1 cDNA protects C. elegans neurons from the toxic effects of expanded huntingtin fragments. A glutamineproline-rich domain, along with a charged domain, is critical for PQE-1 protein function. Analysis of pqe-1 suggests that proteins exist that specifically protect neurons from the toxic effects of expanded polyQ disease proteins.
Figures


Similar articles
-
Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.J Neurosci. 2006 Mar 8;26(10):2830-8. doi: 10.1523/JNEUROSCI.3344-05.2006. J Neurosci. 2006. PMID: 16525063 Free PMC article.
-
Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.Hum Mol Genet. 2006 Mar 15;15(6):1025-41. doi: 10.1093/hmg/ddl017. Epub 2006 Feb 6. Hum Mol Genet. 2006. PMID: 16461334
-
Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity.J Vis Exp. 2021 Sep 21;(175). doi: 10.3791/63081. J Vis Exp. 2021. PMID: 34633391
-
Huntingtin aggregation and toxicity in Huntington's disease.Lancet. 2003 May 10;361(9369):1642-4. doi: 10.1016/S0140-6736(03)13304-1. Lancet. 2003. PMID: 12747895 Review.
-
Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans.J Mol Neurosci. 2004;23(1-2):61-8. doi: 10.1385/JMN:23:1-2:061. J Mol Neurosci. 2004. PMID: 15126693 Review.
Cited by
-
C. elegans electrotaxis behavior is modulated by heat shock response and unfolded protein response signaling pathways.Sci Rep. 2021 Feb 4;11(1):3115. doi: 10.1038/s41598-021-82466-z. Sci Rep. 2021. PMID: 33542359 Free PMC article.
-
Medium- and high-throughput screening of neurotoxicants using C. elegans.Neurotoxicol Teratol. 2010 Jan-Feb;32(1):68-73. doi: 10.1016/j.ntt.2008.12.004. Epub 2009 Jan 6. Neurotoxicol Teratol. 2010. PMID: 19166924 Free PMC article.
-
Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.J Inherit Metab Dis. 2005;28(6):1065-80. doi: 10.1007/s10545-005-0125-7. J Inherit Metab Dis. 2005. PMID: 16435200
-
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6403-8. doi: 10.1073/pnas.0307697101. Epub 2004 Apr 14. Proc Natl Acad Sci U S A. 2004. PMID: 15084750 Free PMC article.
-
Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.Neurobiol Dis. 2010 Oct;40(1):4-11. doi: 10.1016/j.nbd.2010.05.012. Epub 2010 May 19. Neurobiol Dis. 2010. PMID: 20493260 Free PMC article. Review.
References
-
- Zoghbi H. Y. & Orr, H. T. (2000) Annu. Rev. Neurosci. 23 217-247. - PubMed
-
- Huntington's Disease Collaborative Research Group (1993) Cell 72 971-983. - PubMed
-
- Strong T. V., Tagle, D. A., Valdes, J. M., Elmer, L. W., Boehm, K., Swaroop, M., Kaatz, K. W., Collins, F. S. & Albin, R. L. (1993) Nat. Genet. 5 259-265. - PubMed
-
- Vonsattel J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D. & Richardson, E. P., Jr. (1985) J. Neuropathol. Exp. Neurol. 44 559-577. - PubMed
-
- Martin J. B. & Gusella, J. F. (1986) N. Engl. J. Med. 315 1267-1276. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases